Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Accenture
Johnson and Johnson
US Department of Justice
Federal Trade Commission
Citi

Generated: March 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Vonoprazan

« Back to Dashboard

US Patents for Vonoprazan

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vonoprazan ➤ Sign Up Acid secretion inhibitor Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Sign Up
Vonoprazan ➤ Sign Up 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Sign Up
Vonoprazan ➤ Sign Up Proton pump inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Sign Up
Vonoprazan ➤ Sign Up 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Sign Up
Vonoprazan ➤ Sign Up 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Sign Up
Vonoprazan ➤ Sign Up 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors Takeda Pharmaceuticals Company Limited (Osaka, JP) ➤ Sign Up
Vonoprazan ➤ Sign Up Acid secretion inhibitor Takeda Pharmaceutical Company Limited (Osaka-Shi, JP) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Vonoprazan

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Vonoprazan Argentina 055144 2025-08-30 ➤ Sign Up
Vonoprazan Argentina 107852 2025-08-30 ➤ Sign Up
Vonoprazan Austria 504567 2025-08-30 ➤ Sign Up
Vonoprazan Australia 2006285641 2025-08-30 ➤ Sign Up
Vonoprazan Brazil PI0615111 2025-08-30 ➤ Sign Up
Vonoprazan Canada 2621182 2025-08-30 ➤ Sign Up
Vonoprazan China 101300229 2025-08-30 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
Queensland Health
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: